Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (distal convoluted tubule cells) | 0.10 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 31 Parkinson's papers of 7,560 | 0.54 |
| pathways Reactome | 7 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 11949
Sealed predictions
- NANOG in dopamine neurons, braak+0.34 (p 0.374) → +0.47 (p 0.201)receipt 11956
Swarm cases
receipt 11956: NANOG in dopamine neurons, braak
- power
- full sample +0.38 (p 0.125, n 18), 95% CI -0.11 to +0.72. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.38 (p 0.125, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.38 (p 0.125, n 18). could be the mix.
- skeptic
- leave-one-out range +0.28 to +0.47, sign flips 0; without severely affected donors +0.38 (p 0.125, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NANOG in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts